National Research (NRC) Competitors $19.12 -0.34 (-1.75%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRC vs. OABI, MXCT, ABSI, PGEN, NOTV, LUNA, ONMD, PIRS, BIAF, and AIKIShould you be buying National Research stock or one of its competitors? The main competitors of National Research include OmniAb (OABI), MaxCyte (MXCT), Absci (ABSI), Precigen (PGEN), Inotiv (NOTV), Luna Innovations (LUNA), OneMedNet (ONMD), Pieris Pharmaceuticals (PIRS), bioAffinity Technologies (BIAF), and AIkido Pharma (AIKI). National Research vs. OmniAb MaxCyte Absci Precigen Inotiv Luna Innovations OneMedNet Pieris Pharmaceuticals bioAffinity Technologies AIkido Pharma OmniAb (NASDAQ:OABI) and National Research (NASDAQ:NRC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking. Is OABI or NRC more profitable? National Research has a net margin of 18.78% compared to OmniAb's net margin of -308.78%. National Research's return on equity of 67.40% beat OmniAb's return on equity.Company Net Margins Return on Equity Return on Assets OmniAb-308.78% -20.97% -18.05% National Research 18.78%67.40%21.92% Which has more risk & volatility, OABI or NRC? OmniAb has a beta of -0.12, suggesting that its share price is 112% less volatile than the S&P 500. Comparatively, National Research has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Does the media favor OABI or NRC? In the previous week, National Research's average media sentiment score of 0.00 beat OmniAb's score of -0.26 indicating that National Research is being referred to more favorably in the news media. Company Overall Sentiment OmniAb Neutral National Research Neutral Which has better earnings and valuation, OABI or NRC? National Research has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniAb$34.16M16.21-$50.62M-$0.62-6.32National Research$148.58M3.02$30.97M$1.1316.92 Does the MarketBeat Community prefer OABI or NRC? National Research received 88 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 61.67% of users gave National Research an outperform vote. CompanyUnderperformOutperformOmniAbOutperform Votes23100.00% Underperform VotesNo VotesNational ResearchOutperform Votes11161.67% Underperform Votes6938.33% Do analysts recommend OABI or NRC? OmniAb presently has a consensus target price of $9.00, indicating a potential upside of 129.59%. Given OmniAb's stronger consensus rating and higher possible upside, research analysts clearly believe OmniAb is more favorable than National Research.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00National Research 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in OABI or NRC? 72.1% of OmniAb shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 8.6% of OmniAb shares are owned by insiders. Comparatively, 2.0% of National Research shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryNational Research beats OmniAb on 10 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get National Research News Delivered to You Automatically Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRC vs. The Competition Export to ExcelMetricNational ResearchCommercial physical research IndustryBusiness SectorNASDAQ ExchangeMarket Cap$448.94M$4.53B$6.94B$8.85BDividend Yield2.47%1.61%2.84%4.08%P/E Ratio16.9245.2625.9215.74Price / Sales3.0259.44214.9588.25Price / Cash12.7824.0427.1736.92Price / Book13.013.415.206.55Net Income$30.97M$139.66M$124.16M$226.22M7 Day Performance-0.10%2.43%7.03%3.77%1 Month Performance3.74%19.44%16.21%4.64%1 Year Performance-54.19%32.14%35.01%29.21% National Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRCNational ResearchN/A$19.12-1.7%N/A-54.2%$448.94M$148.58M16.92435OABIOmniAb1.6917 of 5 stars$3.88+0.8%$9.00+132.0%-10.9%$458.46M$34.16M-6.217MXCTMaxCyte3.1893 of 5 stars$3.47+0.6%$8.67+149.8%-21.1%$366.02M$41.29M-10.19143ABSIAbsci1.4975 of 5 stars$2.54-0.4%$8.67+241.2%+82.9%$291.74M$5.72M-2.74210PGENPrecigen3.7622 of 5 stars$0.89-1.1%$7.00+683.8%-20.8%$261.56M$6.22M0.00202NOTVInotiv2.1568 of 5 stars$3.44+0.9%$5.92+72.0%+54.1%$89.44M$572.42M-0.892,055News CoverageGap UpLUNALuna Innovations2.2438 of 5 stars$1.69+3.0%$8.00+373.4%-69.5%$57.39M$116.61M-20.50337ONMDOneMedNetN/A$0.83-1.8%N/A-78.4%$23.30M$1.02M0.002PIRSPieris Pharmaceuticals1.6396 of 5 stars$16.17+1.5%N/A+2.8%$21.34M$1.35M-1.33140Analyst UpgradeBIAFbioAffinity Technologies2.4179 of 5 stars$1.21-2.0%$6.00+395.8%-12.9%$18.87M$2.53M-1.5110Gap DownAIKIAIkido PharmaN/A$1.63+3.8%N/A-19.5%$8.94M$10,000.00-0.424 Related Companies and Tools Related Companies OABI Alternatives MXCT Alternatives ABSI Alternatives PGEN Alternatives NOTV Alternatives LUNA Alternatives ONMD Alternatives PIRS Alternatives BIAF Alternatives AIKI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
